NOSTER
DEAD

Serial Number

79202442

Owner

Noster Inc.

Filing Date

Jun 7, 2016

Add to watchlist:

No watchlists yet
View on USPTO

NOSTER Trademark

Serial Number: 79202442 • Registration: 5319552

NOSTER is a trademark filed by Noster Inc. on June 7, 2016. The trademark is classified under Class 1 (Chemicals), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 29 (Meats & Processed Foods), Class 30 (Staple Foods), Class 32 (Light Beverages). The application is currently no longer active.

Owner Contact Info

Noster Inc. (26 trademarks)

35-3, Minamibiraki,

Entity Type: 99

NITTO PHARMACEUTICAL INDUSTRIES, LTD. (14 trademarks)

35-3, Minamibiraki,

Entity Type: 03

Trademark Details

Filing Date

June 7, 2016

Registration Date

October 31, 2017

Published for Opposition

August 15, 2017

Cancellation Date

May 17, 2024

Goods & Services

Tea; roasted, powdered or granulated coffee; coffee beverages; roasted, powdered or granulated cocoa; cocoa beverages; Japanese traditional confectionery; western-style confectionery; bread and buns; sandwiches; steamed buns stuffed with minced meat (Chuka-manjuh); hamburger sandwiches; pizzas; hot dog sandwiches; meat pies; cube sugar; fructose for culinary purposes; crystal sugar, not confectionery; sugar; maltose for culinary purposes; honey; glucose for culinary purposes; powdered starch syrup for culinary purposes; starch syrup for culinary purposes; ice cream mixes; sherbet mixes; flour

Milk products excluding ice cream, ice milk, and frozen yogurt; edible oils and fats; fresh, chilled or frozen meat for human consumption; fresh, chilled or frozen edible aquatic animals not live; processed meat products; processed seafood products other than blocks of boiled, smoked and then dried bonitos (Katsuo-bushi), dried pieces of agar jelly (Kanten), flakes of dried fish meat (Kezuri-bushi), fishmeal for human consumption, edible shavings of dried kelp (Tororo-kombu), sheets of dried laver (Hoshi-nori), dried brown alga (Hoshi-hijiki), dried edible seaweed (Hoshi-wakame) and toasted sheets of laver (Yaki-nori), namely, tinned seafood, processed fish; processed vegetables and fruits; protein for use as a food additive, namely, formed textured vegetable protein for use as a meat substitute and textured vegetable protein for use as a meat extender

Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wrapping wafers for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages; breast-nursing pads; cotton swabs for medical use; dental composite, impression and porcelain materials; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animals

Cosmetics; deodorant soaps and laundry detergents; dentifrices; perfume and flavour materials, namely, natural perfumery prepared from vegetables, natural perfumery prepared from animals, synthetic perfumery, blended perfumery and food flavorings prepared from essential oils; false nails; false eyelashes; breath freshening preparations; deodorants for animals; incenses and fragrances

Lactic acid bacteria powder for producing food, dietary supplements for humans or beverages; biological microorganisms for producing food, dietary supplements for humans or beverages; chemical additives for use in the manufacture of food, pharmaceuticals, cosmetics and animal feed; perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; food preserving chemicals; chemical preparations for preserving foodstuffs; chemical products for the fresh-keeping and preserving of food; chemical products for stabilizing foodstuffs; chemicals for industrial purposes; chemicals for use in the manufacture of a wide variety of goods; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; higher fatty acids for industrial purposes; unprocessed plastic; gluten for the food industry

Whey beverages; carbonated non-alcoholic drinks; fruit juices; vegetable juice; beer; extracts of hops for making beer

Filing History

TOTAL INVALIDATION PROCESSED BY THE IB
Apr 26, 2025 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Apr 7, 2025 INTS
INVALIDATION PROCESSED
Apr 7, 2025 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Jan 18, 2025 INTR
CANCELLED SECTION 71
May 17, 2024 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Oct 31, 2022 REM3
CHANGE OF OWNER RECEIVED FROM IB
Oct 23, 2020 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 13, 2018 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Feb 8, 2018 FICS
FINAL DISPOSITION PROCESSED
Feb 8, 2018 FIMP
CORRECTION UNDER SECTION 7 - PROCESSED
Feb 6, 2018 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Feb 6, 2018 APRE
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 31, 2018 FICR
TEAS SECTION 7 REQUEST RECEIVED
Jan 10, 2018 ES7R
REGISTERED-PRINCIPAL REGISTER
Oct 31, 2017 R.PR
NOTIFICATION PROCESSED BY IB
Aug 18, 2017 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 15, 2017 NPUB
PUBLISHED FOR OPPOSITION
Aug 15, 2017 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 2, 2017 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 2, 2017 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 26, 2017 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2017 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 22, 2017 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 22, 2017 CRFA
ASSIGNED TO LIE
Jun 13, 2017 ALIE
TEAS CHANGE OF CORRESPONDENCE RECEIVED
May 19, 2017 TCCA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 19, 2017 TROA
REFUSAL PROCESSED BY IB
Mar 25, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 7, 2017 RFCS
REFUSAL PROCESSED BY MPU
Mar 7, 2017 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 7, 2017 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 4, 2017 RFCR
NON-FINAL ACTION WRITTEN
Mar 3, 2017 CNRT
ASSIGNED TO EXAMINER
Mar 3, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 2, 2017 REPR